Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4,599 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety of anti-SARS-CoV-2 messenger RNA vaccine in lung cancer patients undergoing anticancer chemotherapy: A multicenter, prospective, observational, patient-reported outcome study.
Harada D, Tamura T, Ninomiya K, Kubo T, Kuyama S, Tachibana S, Inoue K, Chikamori K, Kudo K, Ochi N, Maeda Y, Kiura K. Harada D, et al. Among authors: tamura t. Thorac Cancer. 2023 Jan;14(3):231-236. doi: 10.1111/1759-7714.14737. Epub 2022 Nov 20. Thorac Cancer. 2023. PMID: 36404396 Free PMC article.
[A case of advanced gastric cancer with multiple bone metastases and disseminated intravascular coagulation successfully treated by combination chemotherapy of S-1 plus docetaxel].
Ninomiya K, Mannami T, Seno S, Suzuki Y, Tamura T, Kimura K, Kubo T, Masunari T, Okada T, Kiguchi T, Sezaki N, Harita S, Nakata Y, Sonobe H. Ninomiya K, et al. Among authors: tamura t. Gan To Kagaku Ryoho. 2012 Nov;39(11):1719-22. Gan To Kagaku Ryoho. 2012. PMID: 23152027 Japanese.
Short-term low-volume hydration in cisplatin-based chemotherapy for patients with lung cancer: the second prospective feasibility study in the Okayama Lung Cancer Study Group Trial 1201.
Ninomiya K, Hotta K, Hisamoto-Sato A, Ichihara E, Gotoda H, Morichika D, Tamura T, Kayatani H, Minami D, Kubo T, Tabata M, Tanimoto M, Kiura K. Ninomiya K, et al. Among authors: tamura t. Int J Clin Oncol. 2016 Feb;21(1):81-7. doi: 10.1007/s10147-015-0860-1. Epub 2015 Jun 21. Int J Clin Oncol. 2016. PMID: 26093520
Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations.
Tamura T, Kato Y, Ohashi K, Ninomiya K, Makimoto G, Gotoda H, Kubo T, Ichihara E, Tanaka T, Ichimura K, Maeda Y, Hotta K, Kiura K. Tamura T, et al. Biochem Biophys Res Commun. 2018 Jan 1;495(1):360-367. doi: 10.1016/j.bbrc.2017.10.175. Epub 2017 Oct 31. Biochem Biophys Res Commun. 2018. PMID: 29101033
Successful Desensitization Treatment with Osimertinib after the Development of Osimertinib-induced Urticaria in a Patient Undergoing Treatment for Non-small Cell Lung Cancer Harboring the EGFR T790M Mutation.
Makimoto G, Nishi T, Kawakado K, Nishimura T, Tamura T, Kudo K, Kuyama S. Makimoto G, et al. Among authors: tamura t. Intern Med. 2020 Sep 1;59(17):2161-2164. doi: 10.2169/internalmedicine.4429-20. Epub 2020 May 26. Intern Med. 2020. PMID: 32461525 Free PMC article.
Detection of epidermal growth factor receptor mutations in exhaled breath condensate using droplet digital polymerase chain reaction.
Nishii K, Ohashi K, Tamura T, Ninomiya K, Matsubara T, Senoo S, Kano H, Watanabe H, Oda N, Makimoto G, Higo H, Kato Y, Ninomiya T, Kubo T, Yamamoto H, Tomida S, Hotta K, Tabata M, Toyooka S, Maeda Y, Kiura K. Nishii K, et al. Among authors: tamura t. Oncol Lett. 2020 Dec;20(6):393. doi: 10.3892/ol.2020.12256. Epub 2020 Oct 29. Oncol Lett. 2020. PMID: 33193853 Free PMC article.
4,599 results